申请人:GENENTECH, INC.
公开号:US10202354B2
公开(公告)日:2019-02-12
The present invention relates to compounds useful as inhibitors of one or more histone demethylses, such as KDM2b. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
本发明涉及可作为一种或多种组蛋白去甲基化抑制剂(如 KDM2b)的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物,以及使用所述组合物治疗各种疾病的方法。